Observational Study: Ticagrelor, compared with clopidogrel, is not associated with better outcomes for patients with ACS treated with PCI

Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention – JAMA (free for a limited period)

Editorial: Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes – JAMA (free for a limited period)

Author Interview: Ticagrelor or Clopidogrel for Antiplatelet Therapy After Percutaneous Intervention for Acute Coronary Syndrome? – JAMA

Commentary: Ticagrelor vs. Clopidogrel in Real-Life Patients with Acute Coronary Syndromes: Another View – NEJM Journal Watch

Commentary on Twitter

In @JAMA_current, our article comparing ticagrelor and clopidogrel in patients with an acute coronary syndrome undergoing PCI. A remarkable international collaboration. Bottom line: more expensive med not better. https://t.co/SDAyI7Q1MV pic.twitter.com/RFmmy4qvrW

— Harlan Krumholz (@hmkyale) October 27, 2020